Ono Pharmaceutical Co., Ltd. (OPHLY)
OTCMKTS
· Delayed Price · Currency is USD
4.010
+0.290 (7.80%)
May 6, 2025, 11:27 AM EDT
Ono Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 6, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Market Capitalization | 5,423 | 7,622 | 10,154 | 12,458 | 13,043 | 11,531 | Upgrade
|
| Market Cap Growth | -42.82% | -24.93% | -18.50% | -4.48% | 13.11% | 14.59% | Upgrade
|
| Enterprise Value | 5,347 | 7,043 | 9,448 | 12,065 | 12,357 | 10,749 | Upgrade
|
| Last Close Price | 3.72 | 5.44 | 6.93 | 8.30 | 8.74 | 7.42 | Upgrade
|
| PE Ratio | 11.52 | 9.01 | 11.97 | 18.79 | 19.13 | 20.78 | Upgrade
|
| PS Ratio | 1.75 | 2.29 | 3.02 | 4.19 | 4.66 | 4.24 | Upgrade
|
| PB Ratio | 1.04 | 1.44 | 1.81 | 2.29 | 2.25 | 2.18 | Upgrade
|
| P/TBV Ratio | 1.94 | 1.57 | 2.01 | 2.56 | 2.55 | 2.50 | Upgrade
|
| P/FCF Ratio | 9.70 | 10.81 | 8.75 | 26.86 | 21.54 | 18.61 | Upgrade
|
| P/OCF Ratio | 9.21 | 10.42 | 8.46 | 24.47 | 19.50 | 16.73 | Upgrade
|
| EV/Sales Ratio | 1.58 | 2.12 | 2.81 | 4.05 | 4.42 | 3.96 | Upgrade
|
| EV/EBITDA Ratio | 6.97 | 5.97 | 7.50 | 11.40 | 11.93 | 12.58 | Upgrade
|
| EV/EBIT Ratio | 8.79 | 6.65 | 8.37 | 13.22 | 13.84 | 14.88 | Upgrade
|
| EV/FCF Ratio | 9.57 | 9.99 | 8.14 | 26.01 | 20.41 | 17.35 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.05 | 0.05 | 0.07 | 0.08 | 0.09 | Upgrade
|
| Debt / FCF Ratio | 1.76 | 0.08 | 0.06 | 0.16 | 0.14 | 0.13 | Upgrade
|
| Asset Turnover | 0.49 | 0.56 | 0.55 | 0.49 | 0.44 | 0.44 | Upgrade
|
| Inventory Turnover | 2.26 | 2.72 | 2.54 | 2.31 | 2.38 | 2.41 | Upgrade
|
| Quick Ratio | 2.65 | 2.92 | 1.71 | 2.56 | 1.58 | 1.60 | Upgrade
|
| Current Ratio | 3.55 | 3.99 | 2.81 | 4.27 | 2.64 | 2.47 | Upgrade
|
| Return on Equity (ROE) | 9.18% | 16.56% | 16.02% | 12.39% | 12.49% | 10.59% | Upgrade
|
| Return on Assets (ROA) | 5.56% | 11.16% | 11.57% | 9.32% | 8.69% | 7.31% | Upgrade
|
| Return on Capital (ROIC) | 6.19% | 12.81% | 13.14% | 10.49% | 10.06% | 8.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.10% | 19.80% | 19.80% | 16.50% | 15.10% | 13.30% | Upgrade
|
| Earnings Yield | 8.68% | 11.10% | 8.35% | 5.32% | 5.23% | 4.81% | Upgrade
|
| FCF Yield | 10.30% | 9.25% | 11.43% | 3.72% | 4.64% | 5.37% | Upgrade
|
| Dividend Yield | 14.16% | 9.72% | 7.60% | 5.55% | 5.17% | 5.64% | Upgrade
|
| Payout Ratio | - | 29.05% | 26.38% | 34.36% | 29.76% | 38.15% | Upgrade
|
| Buyback Yield / Dilution | 2.96% | 1.70% | 1.65% | 0.54% | 0.96% | 1.97% | Upgrade
|
| Total Shareholder Return | 17.12% | 11.43% | 9.25% | 6.09% | 6.13% | 7.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.